A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter clinical trial published in the Journal of Clinical Oncology.

For example, some T cells are genetically pre-programmed to protect the skin, while others are specifically selective for the gastrointestinal tract. In the case of poison ivy exposure in a ...

T-cell skin lymphomas are more common than B-cell skin lymphomas. B-cell skin lymphoma, also called cutaneous B-cell lymphoma (CBCL), occurs when a mutation develops in the cell. The mutation ...

Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...

"The complete response rate, consistent treatment response and safety profile across multiple clinical studies to date with HyBryte™ has been exciting to see," noted Dr. Kim, Principal ...

Cutaneous T-cell lymphoma is a group of rare blood cancers that affects the skin. Nine patients have been enrolled and treated with HyBryte over up to 54 weeks. Also Read: Soligenix Kickstarts ...

My research is aimed at developing an improved understanding of new therapies for patients with several less-common types of lymphoma, including T cell lymphomas, cutaneous (skin) lymphomas, Hodgkin ...

The US regulator has cleared Lymphir (denileukin diftitox) for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL ... by debilitating skin lesions and severe itching.

Phototherapy involves the use of ultraviolet light for the treatment of skin disease and many dermatologists have phototherapy units in their offices. With these units, ultraviolet light of ...